Potential vaccine candidates across the world are in the race to become a reality against Covid 19. Pfizer and Moderna released the results of clinical trials of their respective experimental coronavirus vaccines. The duos have reportedly shown an efficacy rate of over 90 percent. in the meantime, the first batch of Russia's Sputnik V vaccine for COVID-19 is expected to reach Kanpur's Ganesh Shankar Vidyarthi Medical College by next week wherein the vaccine's Phase 2 and Phase 3 human clinical trials will be conducted.

As per the Ministry of Health and Family Welfare data updated today, , the total coronavirus cases in the country have climbed to 89,12,907 with 38,617 infections being reported in a day while the death toll climbed to 1,30,993 with 474 new fatalities. The number of active cases remained below 5 lakh for the eighth consecutive day. There are 4,46,805 active cases of coronavirus infection in the country. The total recoveries have surged to 83,35,109 pushing the national recovery rate to 93.52 per cent while the COVID-19 case fatality rate stands at 1.47 per cent. 

According to RDIF CEO Kirill Dmitriev, Sputnik-V coronavirus vaccine is safer than others. He said it is one of the three vaccines in the world backed by published preliminary clinical trial results. Russian President Vladimir Putin recently called for a joint effort by the BRICS nations on the development of the coronavirus vaccines as he suggested that Sputnik-V vaccine could be produced in India and China. Both India and China are members of the five-nation bloc.

Malaysia signs agreement with China for COVID-19 vaccine development

Chinese COVID-19 vaccine appears safe, initial study finds

Iranian companies has started COVID 19 vaccine human trials